Garg Pushkal

EDGAR CIK 0001829252

Alnylam Pharmaceuticals, Inc. - ALNY

Officer
EVP Chief R&D
Direct Buys
0
$0
0 Shares
Direct Sells
8
($5.86) M
-15,119 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/13/2026
02/17/2026
Sell
-2,242 @ $310.08
($695,201) 24,848 (-8.28%) Direct
01/12/2026
01/14/2026
Sell
-1,510 @ $362.87
($547,929) 22,511 (-6.29%) Direct
10/03/2025
10b5-1
10/03/2025
Sell
-3,022 @ $451.48
($1,364,387) 20,221 (-13.00%) Direct
10/02/2025
10/03/2025
Sell
-2,937 @ $452.05
($1,327,675) 23,243 (-11.22%) Direct
08/19/2025
10b5-1
08/19/2025
Sell
-1,455 @ $458.41
($666,987) 20,221 (-6.71%) Direct
08/18/2025
08/19/2025
Sell
-1,396 @ $453.27
($632,759) 21,676 (-6.05%) Direct
03/04/2025
10b5-1
03/05/2025
Sell
-808 @ $241.05
($194,766) 24,542 (-3.19%) Direct
03/03/2025
10b5-1
03/05/2025
Sell
-1,749 @ $243.79
($426,384) 25,350 (-6.45%) Direct